Definium Therapeutics Inc.

DFTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$33.87

-$2.46 (-6.77%)

Nov 2, 2026, 12:01 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	257.84M	273.74M	99.7M	142.14M	133.54M	80.09M
Short-Term Investments	153.76M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	862K	613K	224K	331K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	7.73M	7.88M	4.17M	n/a	n/a	n/a
Total Current Assets	419.32M	281.62M	103.87M	146.06M	137.22M	81.52M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	19.92M	19.92M	20.45M	23.61M	26.79M	n/a
Total Long-Term Assets	20.78M	20.53M	20.67M	23.94M	26.79M	n/a
Total Assets	440.1M	302.15M	124.54M	169.99M	164M	81.52M
Account Payables	5.35M	2.01M	4.14M	2.11M	4.18M	2.02M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	61.35M	30.42M	20.74M	13.03M	2.3M	-462K
Total Current Liabilities	66.7M	38.85M	32.25M	17.89M	10.41M	3.01M
Long-Term Debt	n/a	21.85M	14.13M	n/a	n/a	n/a
Other Long-Term Liabilities	41.08M	n/a	32K	1.18M	1.93M	2.64M
Total Long-Term Liabilities	41.08M	21.85M	14.16M	1.18M	1.93M	2.64M
Total Liabilities	107.77M	60.7M	46.41M	19.08M	12.34M	5.65M
Total Debt	n/a	21.85M	14.13M	72K	n/a	n/a
Book Value	332.33M	241.45M	78.13M	150.92M	151.66M	75.87M
Book Value Per Share	3.72	0.34	2	4.89	5.54	4.27
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-582.67M	-398.88M	-290.2M	-194.47M	-137.67M	-44.64M
Comprehensive Income	1.09M	819K	343K	627K	1.05M	284K
Shareholders Equity	332.33M	241.45M	78.13M	150.92M	151.66M	75.87M
Total Investments	153.76M	n/a	n/a	n/a	n/a	n/a